Interventional Oncology & Embolization
Boston Scientific's Interventional Oncology & Embolization grant supports research and innovation in minimally invasive cancer therapies, including embolization and targeted radiotherapy.
Funder: Boston Scientific
Due Dates: August 17, 2026 | September 14, 2026 | October 12, 2026 | November 4, 2026 | December 1, 2026
Funding Amounts: Award size and duration vary; both cash grants and product donations (e.g., TheraSphere Y-90 Glass Microspheres) are available.
Summary: Supports minimally invasive cancer therapies and product donations for indigent care and humanitarian missions in interventional oncology.
Key Information: Applications must be submitted at least 2 months before event/decision date; only complete applications are considered.
Description
Boston Scientific’s Interventional Oncology & Embolization grant program aims to advance minimally invasive cancer treatments by supporting research, education, and patient care initiatives. The program offers financial support and product donations (notably TheraSphere Y-90 Glass Microspheres) to expand access to innovative therapies, particularly for indigent care and humanitarian medical missions. Funding is available for eligible organizations to implement projects that improve patient outcomes in interventional oncology.
